Brensocatib did not improve the clinical status of patients hospitalized with severe SARS-CoV-2 infection in the double-blind randomized, placebo-controlled STOP-COVID19 multicenter clinical trial, according to research published ...
May 18, 2022
0
5
A new study has suggested that treatment to target necroptosis in muscle fibers using a necroptosis inhibitor lessens myositis-induced muscle weakness as well as muscle cell death and inflammation in the muscles. This has ...
Mar 1, 2022
0
55
Inhibition of Ubiquitin Specific Peptidase 47 (USP47) was identified as a novel therapeutic target for hematologic malignancies bearing mutant oncoprotein EZH2, according to scientists from the Hefei Institutes of Physical ...
Jan 27, 2022
0
20
Multisensory integration has been recently shown to produce a larger pupil size than unisensory constituents. Superior colliculus (SC), an important laminar nucleus in the midbrain, not only engages in spatial attention and ...
Aug 11, 2021
0
2
A new study has identified early risk factors that predicted heightened anxiety in young adults during the coronavirus (COVID-19) pandemic. The findings from the study, supported by the National Institutes of Health and published ...
Feb 12, 2021
0
3
Toshinori Chiba and his collaborators have proposed an innovative new reciprocal inhibition model of post-traumatic stress disorder (PTSD), which may aid considerably in its treatment. This model comprehensively explains ...
Jul 20, 2020
0
46
Balance is the key. It's not exactly neuroscience; except that it is.
Jun 12, 2019
0
39
Korean researchers have identified the inhibition of autophagy in microglia, brain immune cells. It is expected to help develop treatments for Alzheimer's disease which occur due to the inhibition of autophagy.
Jan 18, 2019
0
5
According to estimates from the World Health Organization (WHO), there will be 18.1 million new cases and 9.6 million cancer deaths worldwide in 2018. Cancer is a serious disease that affects people all over the world. And ...
Jan 16, 2019
0
7
Monoamine oxidase (MAO) inhibitors are potential drug candidates for treating neurological disorders such as anxiety, Alzheimer's disease and Parkinson's disease.
Jan 2, 2019
0
1
